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Abstract: A novel model of drug release from 2D-HPMC matrices  is considered. Detailed 
mathematical description of matrix swelling and the effect of the initial drug loading are 
introduced. A numerical approach to solution of the posed nonlinear 2D problem is used on 
the basis of finite element domain approximation and time difference method. The reliability 
of the model is investigated in two steps: numerical evaluation of the water uptake 
parameters; evaluation of drug release parameters under available experimental data. 
The proposed numerical procedure for fitting the model is validated performing different 
numerical examples of drug release in two cases (with and without taking into account initial 
drug loading). The goodness of fit evaluated by the coefficient of determination is presented 
to be very good with few exceptions. The obtained results show better model fitting when 
accounting the effect of initial drug loading (especially for larger values). 
 
Keywords: Drug release, Diffusion, Hydroxypropyl methylcellulose swelling, Finite element 
to modeling, Difference scheme. 
 
Introduction 
Polymeric matrices containing hydroxypropyl methylcellulose (HPMC) are widely used for 
preparation of sustained-release drug carriers [3]. An important characteristic property of 
HPMC is that upon contact with biological fluid (e. g. gastrointestinal fluid or water) it swells 
significantly changing its micro- and macrostructure. 
 
A comprehensive mathematical model (so called “sequential layer” one) describing drug 
release from HPMC-based matrix tablets has been developed during the last decade [10, 11, 
13-15]. This model is implemented by using finite difference method which leads to some 
limitations when generalizing model equations, initial and boundary conditions. Recently a 
new variant of the sequential layer model was developed introducing a detailed mathematical 
description of matrix swelling [6]. A new finite element (FE) approach to modeling drug 
release from 2D polymeric matrices was also proposed [4, 5]. It is based on FE domain 
approximation and an appropriate time difference method which allows solving strongly 
nonlinear model problems of the considered type. This model variant was additionally 
improved taking into account the effect of the initial drug content [7]. 
 
The aim of the present paper is to investigate the reliability of the above model for different 
drugs accounting the effect of the Initial Drug Loading (IDL) on swelling and drug release 
kinetics. A numerical procedure for evaluation of the water uptake parameters when fitting 
the model to available experimental data was developed, as a first step. The numerical 
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parameters, as a second step. Noncommercial software corresponding to the above procedures 
was created and validated. 
 
Model problem 
Drug release from a cylindrical matrix of radius R0 and height 2H0 is considered completely 
surrounded by a biological fluid or water (schematically presented in Fig. 1a). It is assumed: 
(1) main controlling mechanisms of drug kinetics are water penetration into the matrix, drug 
diffusion and matrix swelling; (2) drug dissolution is neglected as very rapid in respect to the 
other processes; (3) matrix swelling is ideal throughout the system – the sum of the volumes 
of water, drug and polymer are always equal to the total system volume and there is no 
volume contraction upon mixing; (4) the water concentration at the tablet surface is at its 
equilibrium value; (5) perfect sink conditions are maintained; (6) water imbibing as well as 
drug loss in axial and radial direction leads to a volume increase/decrease in axial and radial 
direction that is proportional to the relative surface area in the considered direction;   
(7) polymer dissolution is slower in comparison with the considered controlling mechanisms 
[13, 14].  
 
               
 (a)  (b) 
Fig. 1 a) Schematic representation of drug release from a cylindrical tablet;  
b) The domain Ω  with boundary  12 = ∪ Γ ΓΓ  as a quarter of the axial cross section. 
 
The model equations describing the controlling processes in a cylindrical matrix occupying 
the domain 
2 Ω R ⊂  (Fig. 1b) are as follows: 
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where:  eq c C c / 1 1 = ,  in c C c / 2 2 = ,  , eq in cc ,  11 21 () () Dc,Dc, t and  f t  are the dimensionless 
concentration of the penetrating water and drug, the equilibrium water concentration, the 
initial drug concentration, the concentration dependent water and drug diffusivity, the time 
and the final moment under consideration, respectively.  
 
The Fujita-type exponential dependences of the diffusion coefficients are considered [9]:  
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() ( ) () 11 1, 1 , 2 ii e q i Dc De x p β ci =− − =  (3) 
 
where  eq eq D D 2 1 ,  are the diffusion coefficients in the equilibrium swollen state of the system 
and  12 , β β  are dimensionless constants characterizing the concentration dependence. 
 
The model problem is posed under the following initial and boundary conditions: 
 
() 1 00 cx , y , = ,  0 0 0 , 0 H y R x ≤ ≤ ≤ ≤  (4) 
() 2 01 cx , y , = ,  0 0 0 , 0 H y R x ≤ ≤ ≤ ≤  (5) 
 
() 1 1 cx , y , t= , 0 f tt < ≤ ,    t t H y R x ≤ ≤ = 0 ,   or   0 , tt x RyH ≤ ≤=  (6) 
() 2 0 cx , y , t= , 0 f tt < ≤ ,    t t H y R x ≤ ≤ = 0 ,   or   0 , tt x RyH ≤ ≤=  (7) 
 
where  0 0, H R  are the initial dimensions of the tablet and  t t H R ,  are the current ones. 
 
The basic equations describing matrix volume changes in time are the following: 
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where  12 M ,M  are the masses of water and drug corresponding to the domain under 
consideration Ω  with volume V and  1 ρ ,  2 ρ  are the water and drug density, respectively. The 
first equation of (8) describes the increase in matrix volume (swelling due to water 
penetration) while the second equation describes the decrease in matrix volume corresponding 
to the decrease of drug concentration in the tablet. 
 
The fractional drug release and water uptake are expressed as follows: 
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where  t S  is the area of the current cross-sectional domain  t Ω . 
 
FE approach. Formulae of volume changes 
FE discretization of the domain  t Ω  is performed and the numerical solution of the following 
initial matrix problem equivalent to (1) – (7) is sought at each time step [6, 7]: 
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where  1 C  and  2 C  are vectors with elements FE nodal values of  1 C  and  2 C  and 
,, CM ST1 ST2 are FE matrices generated under the current FE mesh. The unit vector is 
denoted with I. An appropriate predictor-corrector hybrid scheme is proposed for solving the 
above problem.  
 
The matrix volume changes due to the water penetration into the tablet and drug release from 
it are considered in two main directions – radial and axial. We assume these volume changes 
realize in two steps in each time interval: tablet swelling caused by the water uptake first and 
tablet volume decrease caused by drug release. Integrating Еq. (8) for each volume element 
(cylindrical domain, corresponding to the k
th layer in y-direction with one and the same radial 
cross-section) and taking into account the assumption (6) when posing the model problem the 
following formulas for change of the thickness of each volume element in y-direction are 
derived: 
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where  1
k
n y + ∆  and  1 ∆
k
n y +  are the thickness after swelling and the final thickness of the k
th layer 
at (n + 1) time level. The average water and drug concentration for the k
th layer at (n + 1) time 
level is denoted by 
k
n c 1 , 1 +  and 
k
n c 1 , 2 + , respectively. They are calculated in terms of the nodal 
concentration values obtained from (10) – (12). The half thickness of the tablet is finally 
evaluated at each time level as follows:  
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Integrating Eq. (8) for the whole cylindrical domain the following change in radius is 
expressed at each time step: 
 
()
()
( )
()
11 , 1 22 ,
11 1
11 1 , 1 12 2 , 1
,
ne q n n i n n
nn nn
ne q n ni n n
Hc c H c c
RR RR
Hc c Hc c
ρρ
ρρ
+
++ +
++ ++
−−
==
−−


  (15) 
 
Reliability of the model 
The reliability of the model is investigated consecutively for HPMC matrices as follows: 
 
Step I 
Numerical evaluation of the water uptake model parameters  eq D1  and  1 β  on the basis of 
available experimental data. 
 
Step II 
Numerical evaluation of the drug model parameters  eq D2  and  2 β  under determined water 
uptake parameters and available experimental data for drug release. 
 
The numerical evaluation of the considered couples is performed introducing the objective 
functions [1, 2]:   INT. J. BIOAUTOMATION, 2010, 14(1), 27-36 
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where 
n
num
n
num R U ,  are the numerical values of water uptake and drug release at the moment 
under consideration with number n and  ,
nn
exp exp UR  are the corresponding experimental data; 
2 1, G G  are the domains of admissible values of  eq eq D D 2 1 ,  and 
k k β β 2 1 , are character 
consistent values of  2 1 , β β . A method of consecutive restrictions of the admissible values is 
used when optimizing the objective functions.  
 
To evaluate the goodness of fit the coefficient of determination was calculated at each step as 
follows [8, 15]: 
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where 
n
arithm U  and 
n
arithm R  is the arithmetic mean of the experimental data of the considered 
water uptake and drug release, respectively. 
 
Numerical evaluation of the water uptake parameters 
Numerical evaluation of the water uptake parameters  eq D1  and  1 β  is performed for the tablets 
with sizes of R = 0.4 cm and H = 0.18 cm on the basis of the available experimental data 
presented in Fig. 2 [13, 16]. It is shown a very good agreement, especially for the first   
8 hours, with the numerical values obtained under 
62 - 1
1 23 1 0 c m s eq D.
− = ×⋅  and  1 5 β = . The 
value of Determination Coefficient (DC) is 0.95. 
 
Numerical evaluation of the drug release parameters 
Release of three different drugs from HPMC tablets is investigated under the obtained values 
of the water uptake parameters. The parameters of drug release  eq D2  and  2 β  are evaluated in 
two cases: with and without taking into account the IDL, i.e. under different formulas for 
tablets volume change corresponding to our two variants of the model presented in [7] and 
[6], respectively. 
 
Example 1  
Both variants of the model are fitted to the experimental data for propranolol hydrochloride 
release from tablets of sizes R = 0.65 cm and H = 0.069 cm at 
3 0 109g cm in c.
− =⋅ [13]. The 
following values for the drug parameters are obtained: 
72 - 1
2 57 1 0 c m s eq D.
− = ×⋅ ,  2 15 β =  
(with IDL = 10%) and 
72 - 1
2 69 1 0 c m s eq D.
− =× ⋅ ,  2 15 β =  (without taking into account IDL). 
A very good agreement between the numerical and experimental results in both cases is 
shown in Fig. 3 (DC = 0.992, DC = 0.986).  
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Example 2   
The release of chlorpheniramine maleate from tablets with sizes of R = 0.6 cm and   
H = 0.23 cm is presented in Fig. 4 in comparison with available experimental data [14] under 
the obtained values: 
721
2 59 1 0 c m s eq D.
− − =× ⋅ ,  2 3 β =  (with IDL = 60% and 
3 05 8g c m in c.
− =⋅ ); 
721
2 97 1 0 c m s eq D.
−− =× ⋅ ,  2 1 β =  (without taking into account IDL). 
Obviously, accounting higher IDL is essential for more accurate simulation of the considered 
drug release (DC is 0.96 against 0.89 without accounting IDL). 
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Fig. 2 Comparison of the water uptake numerical results with the corresponding experimental 
ones under the evaluated parameters  eq D1  and  1 β  
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Fig. 3 Fit of the both model variants to experimental data for propranolol hydrochloride 
release: with IDL = 10% (continuous curve); without taking into account IDL (dashed curve). 
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The experimental results for the release of the same drug but at IDL = 10% (corresponding to 
3 01 0 9g c m in c.
− =⋅ ) presented in Fig. 5 show approximately a linear behavior after the first 
hour [14]. The considered model is not enough reliable in this case under the obtained 
values
72 - 1
2 34 5 1 0 c m s eq D.
− =× ⋅ ,  2 2 β =  (DC = 0.84). 
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Fig. 4 Fit of the both model variants to experimental data for chlorpheniramine maleate 
release: with IDL = 60% (continuous curve); without taking into account IDL (dashed curve). 
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Fig. 5 Fit of the new model [7] to experimental data for chlorpheniramine maleate release 
with IDL = 10% (continuous curve) 
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Example 3   
Molsidomin drug release from tablets with sizes of R = 0.4 cm and H = 0.15 cm at IDL = 4% is 
presented in Fig. 6 under the drug release parameters obtained from the fit of the new model 
[7] to experimental data [12]. An approximately good correspondence is obtained for the 
determined values
72 - 1
2 57 5 1 0 c m s eq D.
− = ×⋅ ,  2 4 β =  at 
3 00 5g c m in c.
− =⋅  (DC = 0.89). 
 
 
 
Fig. 6 Fit of the new model [7] to experimental data for molsidomine release  
with IDL = 4% (continuous curve) 
 
Conclusion 
The reliability of the recently developed novel model (an improved version of the “sequential 
layer” one) for drug release from 2D-HPMC matrices [6, 7] is investigated. This model 
proposes a detailed mathematical description of tablet swelling and contraction due to water 
uptake and drug release. Its improved version takes into account the effect of the initial drug 
loading on swelling and drug release kinetics. 
 
A numerical procedure for evaluation of two water uptake parameters when fitting the model 
to available experimental data is developed, as a first step. As a second step, a procedure for 
evaluation of drug release parameters is introduced under the evaluated water uptake 
parameters. Noncommercial software corresponding to the above procedures is created.     
 
In order to validate the whole procedure for fitting the model, numerical examples of drug 
release for three different drugs (propranolol hydrochloride, chlorpheniramine maleate and 
molsidomine) in two cases (with and without taking into account initial drug loading) are 
performed. The obtained results show better model fitting when taking into account the effect 
of IDL (especially for larger values). The values of determination coefficient corresponding to 
goodness of fit are in the range  84 . 0 99 . 0 ÷ . The worst result can be explained with 
approximately linear behavior of the corresponding experimental data. 
 
The investigated novel model can be used as a cheap and effective simulation tool when 
designing new pharmaceutical products with HPMC carriers.    
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